Hydrocortisone inhibits mucin secretion from guinea pig gallbladder

Area of Science:

• Gastroenterology
• Pharmacology
• Cell Biology

Background:

• Phospholipase A2 (PLA2) plays a key role in inflammatory pathways.
• Prostaglandins and mucins are important mediators in gallbladder physiology.
• Hydrocortisone is a known inhibitor of PLA2.

Purpose of the Study:

• To investigate the effect of hydrocortisone on mucin secretion and prostaglandin release in guinea pig gallbladder explants.
• To elucidate the mechanism by which hydrocortisone exerts its effects, particularly concerning arachidonate metabolism.

Main Methods:

• Guinea pig gallbladder explants were used to study basal and arachidonate-stimulated mucin secretion and prostaglandin release.
• Mucin secretion was quantified using [3H]glucosamine as a precursor.
• Prostaglandin levels were measured by radioimmunoassay for 6-keto-prostaglandin F1 alpha.

Main Results:

• Hydrocortisone sodium succinate demonstrated a dose-dependent, reversible inhibition of basal mucin secretion.
• Hydrocortisone also significantly inhibited arachidonate-stimulated mucin secretion.
• The release of prostaglandin F1 alpha was significantly inhibited by hydrocortisone under both basal and stimulated conditions.

Conclusions:

• Hydrocortisone effectively inhibits both mucin secretion and prostaglandin release in guinea pig gallbladders.
• The inhibitory effect is mediated by the suppression of arachidonate hydrolysis from membrane phospholipids.
• Findings suggest exogenous arachidonate is incorporated into membrane phospholipids before conversion to prostaglandins.